Rigel to Present at the 2024 Cantor Global Healthcare Conference

Rigel Pharmaceuticals (Nasdaq: RIGL), a biotechnology company focused on hematologic disorders and cancer, announced its participation in the 2024 Cantor Global Healthcare Conference.

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL), a biotechnology company focused on hematologic disorders and cancer, announced its participation in the 2024 Cantor Global Healthcare Conference. CEO Raul Rodriguez will present a company overview on September 19, 2024, at 9:10 am ET in New York.

The presentation will be accessible via live webcast through Rigel's Investor Relations website. Founded in 1996 and based in South San Francisco, Rigel is dedicated to developing novel therapies for patients with hematologic disorders and cancer. Investors can access more information about Rigel's products and pipeline on their official website.

Argus Session date unavailable

-0.15% session move Open Argus

Details

News Market Reaction – RIGL

The recorded move for RIGL in the trading session of this news was -0.15%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Sept. 12, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Cantor Global Healthcare Conference on Thursday, September 19, at 9:10 am ET in New York, NY.

To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:
Investors: 
Rigel Pharmaceuticals, Inc. 
650.624.1232 
ir@rigel.com

Media:
David Rosen 
Argot Partners 
212.600.1902 
david.rosen@argotpartners.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-2024-cantor-global-healthcare-conference-302245905.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Rigel Pharmaceuticals presenting at the Cantor Global Healthcare Conference in 2024?

Rigel Pharmaceuticals (RIGL) will present at the Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 9:10 am ET in New York, NY.

Who will be presenting for Rigel Pharmaceuticals at the 2024 Cantor Global Healthcare Conference?

Raul Rodriguez, the president and CEO of Rigel Pharmaceuticals (RIGL), will present the company overview at the 2024 Cantor Global Healthcare Conference.

How can investors access Rigel Pharmaceuticals' presentation at the 2024 Cantor conference?

Investors can access the live webcast or archived recording of Rigel Pharmaceuticals' (RIGL) presentation through the Investor Relations section of the company's website at www.rigel.com.

What is the main focus of Rigel Pharmaceuticals (RIGL) as mentioned in the 2024 conference announcement?

Rigel Pharmaceuticals (RIGL) is described as a commercial stage biotechnology company focused on hematologic disorders and cancer, dedicated to discovering, developing, and providing novel therapies for patients in these areas.

Where is Rigel Pharmaceuticals (RIGL) headquartered according to the 2024 conference press release?

According to the press release, Rigel Pharmaceuticals (RIGL) is based in South San Francisco, California.